Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
- Baudax Bio, Inc. (NASDAQ: BXRX) gained 109% to $0.6287 after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors.
- Chico's FAS, Inc. (NYSE: CHS) shares climbed 61.7% to $7.45 following the announcement of its acquisition by Sycamore Partners for $1 billion.
- Aditxt, Inc. (NASDAQ: ADTX) gained 57% to $20.47.
- Axcella Health Inc. (NASDAQ: AXLA) rose 31.3% to $9.08.
- Inpixon (NASDAQ: INPX) shares gained 23.6% to $0.1729 after gaining around 10% on Wednesday.
- Soleno Therapeutics, Inc. (NASDAQ: SLNO) jumped 22.2% to $25.25. Soleno Therapeutics reported pricing of approximately $120 million underwritten public offering of common stock and concurrent private placement of common stock and/or pre-funded warrants.
- Aytu BioPharma, Inc. (NASDAQ: AYTU) gained 22% to $2.33 following fourth-quarter results.
- Organogenesis Holdings Inc. (NASDAQ: ORGO) gained 20.4% to $3.19.
- Sarcos Technology and Robotics Corporation (NASDAQ: STRC) gained 20% to $0.80 after the company announced it was awarded a $13.8 million USD contract by the U.S. Air Force for the advancement of its AI and machine learning software.
- Adamas One Corp. (NASDAQ: JEWL) gained 18% to $0.9200.
- USA Compression Partners, LP (NYSE: USAC) climbed 14.7% to $25.94.
- Gritstone bio, Inc. (NASDAQ: GRTS) gained 14.2% to $1.36.
- Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 13.7% to $4.08. Connexa Sports Technologies recently announced that it received a letter from the Nasdaq regarding the late filing of its quarterly report.
- VinFast Auto Ltd. (NASDAQ: VFS) climbed 13.6% to $12.73 following a report suggesting the company is planning to set up a manufacturing plant in India.
- Gritstone bio, Inc. (NASDAQ: GRTS) shares rose 13.5% to $1.3550 after the company announced it was awarded a BARDA contract to conduct a Phase 2b comparative study evaluating a next-generation vaccine candidate for COVID-19 valued at up to $433 million.
- Jabil Inc. (NYSE: JBL) gained 11.4% to $117.19 after the company reported mixed fourth-quarter results and issued first-quarter EPS guidance above estimates. The company also increased its current share repurchase authorization to $2.5 billion.
- Suburban Propane Partners, L.P. (NYSE: SPH) climbed 10.7% to $16.25.
- Sigma Additive Solutions, Inc. (NASDAQ: SASI) gained 10.4% to $3.3160.
- Concentrix Corporation (NYSE: CNXC) climbed 9.7% to $81.28 following third-quarter results.
- Sunoco LP (NYSE: SUN) gained 8.8% to $51.50.
- Sprout Social, Inc. (NASDAQ: SPT) rose 6.2% to $50.46. Cantor Fitzgerald maintained Sprout Social with a Neutral and raised the price target from $44 to $48.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) shares fell 61.8% to $2.1050 after the company announced pricing of a public offering of units.
- Capstone Green Energy Corporation (NASDAQ: CGRN) declined 58% to $0.2497. Capstone Green Energy entered into transaction support agreement with senior secured lender.
- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) fell 51.5% to $0.1901 after the company announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS.
- Scienjoy Holding Corporation (NASDAQ: SJ) dipped 34.3% to $2.53. The company unveiled key advancements in its metaverse undertakings.
- SciSparc Ltd. (NASDAQ: SPRC) fell 29.9% to $3.7779.
- mCloud Technologies Corp. (NASDAQ: MCLD) declined 26.6% to $0.1310.
- GigaCloud Technology Inc. (NASDAQ: GCT) declined 24.2% to $7.18 after Culper Research issued a short report on the stock.
- Genasys Inc. (NASDAQ: GNSS) fell 23.8% to $1.9494 after the company priced its 5 million share common stock offering at $2 per share.
- Renalytix Plc (NASDAQ: RNLX) fell 23.7% to $1.4950 after the company announced weak FY sales.
- ShiftPixy, Inc. (NASDAQ: PIXY) fell 22.2% to $0.8170. ShiftPixy shares jumped 141% on Wednesday after the company announced its 1-for-24 reverse stock split effective date.
- Edesa Biotech, Inc. (NASDAQ: EDSA) fell 20.3% to $0.6250 after the company published data from a Phase 2 substudy of its ARDS candidate.
- Turbo Energy, S.A. (NASDAQ: TURB) fell 19.3% to $2.11.
- NextEra Energy Partners, LP (NYSE: NEP) tumbled 17% to $31.09 following downgrades. Oppenheimer downgraded the stock from Outperform to Perform and JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $69 to $40.
- American Coastal Insurance Corporation (NASDAQ: ACIC) fell 16.3% to $7.48.
- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) dipped 16% to $21.52.
- Worthington Industries, Inc. (NYSE: WOR) fell 14.2% to $61.00 after the company reported mixed first-quarter financial results.
- Lead Real Estate Co., Ltd (NASDAQ: LRE) fell 13.8% to $5.35 after declining 11% on Wednesday. Lead Real Estate priced its IPO at $7.00 per ADS.
- Anzu Special Acquisition Corp I (NASDAQ: ANZU) fell 13.5% to $5.62.
- Opera Limited (NASDAQ: OPRA) shares fell 13.2% to $12.76 after the company reported a proposed secondary follow-on public offering of 6.87 million American Depositary Shares.
- Near Intelligence, Inc. (NASDAQ: NIR) fell 13.1% to $0.2673. Near Intelligence received a decision to grant European patent number EP4024906 Titled "Method For Identifying A Device Using Attributes And Location Signatures From The Device."
- XWELL, Inc. (NASDAQ: XWEL) fell 12.8% to $2.12. XWELL shares fell over 25% on Wednesday after the company announced a 1-for-20 reverse stock split.
- CureVac N.V. (NASDAQ: CVAC) fell 12.5% to $6.22 after the company announced the Regional Court Düsseldorf has decided to suspend proceedings on four intellectual property rights in the infringement lawsuit filed by CureVac against BioNTech.
- Workday, Inc. (NASDAQ: WDAY) shares dipped 10.1% to $207.72 after the company lowered its longer-term annual subscription growth guidance late Wednesday. Following this, several analysts cut their respective price target on the stock.
- CarMax, Inc. (NYSE: KMX) fell 9.6% to $71.98 after the company reported mixed second-quarter financial results.
- Mobile Global Esports Inc. (NASDAQ: MGAM) shares fell 9.1% to $0.1741 after gaining over 22% on Wednesday.
- PureTech Health plc (NASDAQ: PRTC) fell 8.9% to $23.22.
- Rush Street Interactive, Inc. (NYSE: RSI) fell 8.1% to $4.53.
- Synlogic, Inc. (NASDAQ: SYBX) shares fell 8% to $3.8501 after declining 15% on Wednesday. Synlogic announced a 1-for-15 reverse stock split.
- SeaStar Medical Holding Corporation (NASDAQ: ICU) fell 7.9% to $0.1741 after gaining around 5% on Wednesday.
- Accenture plc (NYSE: ACN) fell 6% to $295.46 after the company reported mixed fourth-quarter financial results and issued FY24 adjusted EPS guidance below estimates.
- Rite Aid Corporation (NYSE: RAD) shares fell 5.9% to $0.4797 after gaining 19% on Wednesday.
- Micron Technology, Inc. (NASDAQ: MU) shares fell 3.7% to $65.72. Micron posted upbeat results for its fourth quarter. However, the company said it sees a wider-than-expected loss for the first quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.